LABT Lakewood-Amedex Biotherapeutics Inc.

NASDAQ
$0.93

Lakewood-Amedex Biotherapeutics Inc. (LABT) Institutional Ownership

What the institutions did with LABT last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to.

No institutional holdings on record for LABT.